Drug Repurposing Market Size By Regional Analysis(Europe, Asia Pacific, America, Middle East And Africa), By Demand & COVID-19 Impact Analysis, By Type, By Applications And Forecasts 2023 - 2030 (Financial Impact Analysis)

Report Overview

The Market Research Update provide detailed report study and highlights market share and size, and regional changing trends, production value predication, new prospects for Drug Repurposing market development rate. This study report offers a current scenario of the market. The report also comprises a several market dynamics.

The Drug Repurposing is projected to rise moderately in the projected time frame of 2023-2030.

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
The global Drug Repurposing market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2030, growing at a CAGR of xx% during 2023-2030. The objectives of this study are to define, segment, and project the size of the Drug Repurposing market based on company, product type, end user and key regions.

This report studies the global market size of Drug Repurposing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug Repurposing in these regions.
This research report categorizes the global Drug Repurposing market by top players/brands, region, type and end user. This report also studies the global Drug Repurposing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Objectives of Research:

• The overview of the global Drug Repurposing market


• Report comprised of the market companies, to describe and define and analyze the Drug Repurposing market value, share competition landscape, development plans and SWOT analysis.


• The report also involves the structure of the industry by identifying its several sub-segments.


• To observe the industry with reverence to individual future prospects, development trends, and contribution to the overall market.

Major Players in the Market:
The major competitors working in the market are:
, Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, NuMedii

Market by Order Type

Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Market size by End User
Hospitals
Ambulatory Surgical Centers
Others

Regions Covered in the Report are:

• North America


• Europe


• Asia Pacific


• Middle East & Africa


• Rest of the World

Our team of enthusiastic analysts, research experts, and experienced forecasters work precisely to produce such kind of market report. The research report defines USD values, CAGR (compound annual growth rate) values and their variations for the precise projected time frame.

Before you Purchase get some Insights from this report

The research information and studies associated with participant analysis keep the competitive landscape noticeably into the focus with which the market can select or advance their own policies to increase in the market growth.

The Key Questions Answered In Market Report Are:

• Summary of the Drug Repurposing market comprising definition


• Drug Repurposing Market Growth Drivers, Restrains, Challenges and opportunities


• Major trends which is impacting the global Drug Repurposing market


• Drug Repurposing Market segmentation and complete information about the market


• Regional analysis of the market


• Which regional market will develop as a champion at intervals in the coming years?


• What are the top companies at intervals in the global Drug Repurposing market?


• What are the growth strategies of the key players to sustain hold at intervals in the global Drug Repurposing market?

Table of Content

Drug Repurposing Market – Overview
1.1 Definitions, Overview, and Scope
1.2 Drivers, Restrain, Challenges, Opportunities

Drug Repurposing Market – Executive Summary
2.1 Market Revenue and Major Trends, and Challenges

Drug Repurposing Market – Comparative Analysis
3.1 Product Benchmarking
3.2 Financial Overview
3.3 Market Cost Divided
3.4 Estimating Examination

Drug Repurposing Market – Industry Market Entry Scenario
4.1 Governing Outline Summary
4.2 New Business index
4.3 Case Studies of Positive Schemes

Drug Repurposing Market Forces
5.1 Market Drivers
5.2 Market Restrains
5.3 Market New Opportunities
5.4 Market Challenges
5.4 Porters five force model

Drug Repurposing Market – Strategic Complete Overview
6.1 Value Chain Analysis
6.2 Market Opportunities Analysis
6.3 Market Challenges Analysis
6.4 Market Life Cycle

Drug Repurposing Market – By Regions (Market Size –USD Million)
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Middle East and Africa
7.5 Rest of the World

Customization:
We also provide customized reports according to customer\'s specific requirements. We also provide customization for regional and country-level reports individually.

Request Free Sample